Assessment of Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension
Echocardiography · 2026-06 · 43 (6)
DOI: 10.1111/echo.70444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Echocardiography, online erschienen am 03.06.2026. Verfasst von Zhen-Yun Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Ultrasound, Tengzhou Central People's Hospital, Tengzhou, China. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Echocardiography, Pulmonary Embolism, Heart Atria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
Chronic thromboembolic pulmonary hypertension (CTEPH) leads to right atrial (RA) dysfunction, which correlates with poor prognosis. However, most studies on RA function in pulmonary hypertension (PH) focus on heterogeneous PH etiologies, with limited data on CTEPH alone. This study aimed to assess RA function in CTEPH patients using standard two‐dimensional (2DE) and M‐mode echocardiography, and validate the clinical value of RA‐related parameters.
Methods
We enrolled 91 CTEPH patients and 30 healthy controls. RA volume/function parameters (maximal volume index [RAVmaxI], total/passive/active emptying fractions [TotEF/PassEF/ActEF]) and tricuspid annular plane systolic excursion (TAPSE, decomposed into atrial [TAPSEra] and ventricular [TAPSErv] components; TAPSEra% = TAPSEra/TAPSE) were measured via 2DE/M‐mode echocardiography. Correlations with clinical (WHO functional class [WHO‐FC], 6‐min walk distance [6MWD]) and laboratory (NT‐proBNP) indices were analyzed; receiver operating characteristic (ROC) curves evaluated predictive value for WHO‐FC ≥ III.
Results
Compared to controls, CTEPH patients had higher RAVmaxI (43.46 ± 13.34 vs. 22.52 ± 2.89 mL/m 2 , P < 0.001), lower TotEF (39.45 ± 9.43 vs. 50.07 ± 7.52%, P < 0.001) and PassEF (14.33 ± 6.43 vs. 30.03 ± 5.26%, P < 0.001), and higher ActEV/TotEV (59.76 ± 17.37 vs. 34.05 ± 12.75%, P < 0.001). TAPSEra% was higher in CTEPH patients (58.69 ± 19.54 vs. 30.52 ± 7.92%, P < 0.001). RAVmaxI (≥37.47 mL/m 2 , AUC = 0.899, sensitivity = 75.4%, specificity = 91.7%) and TAPSEra% (≥45.05%, AUC = 0.849, sensitivity = 90.2%, specificity = 70.0%) effectively predicted WHO‐FC ≥ III (both P < 0.001).
Conclusions
Impaired RA reservoir and conduit functions are hallmarks of CTEPH, with compensatory active contraction counteracting the reduction in passive filling. Given their noninvasive nature and high reliability, RAVmaxI and TAPSEra% are valuable indices for identifying patients with WHO‐FC ≥ III and quantifying CTEPH severity, justifying their integration into standard echocardiographic protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Ultrasound, Tengzhou Central People's Hospital, Tengzhou, China.
- Department of Ultrasonic Medicine, Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), Jinan, China.
- Department of Diagnostic Ultrasound, The Second Hospital of Tianjin Medical University, Tianjin, China.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Sun, Z. Y., Zhao, X. X., Pan-Han, Li, J., Zhang, M. W., Zhu, L., & Li, Q. (2026). Assessment of Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension. Echocardiography, 43(6). https://doi.org/10.1111/echo.70444
Vancouver
Sun ZY, Zhao XX, Pan-Han, Li J, Zhang MW, Zhu L, et al. Assessment of Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension. Echocardiography. 2026;43(6). doi:10.1111/echo.70444
BibTeX
@article{Sun2026,
author = {Sun, Zhen-Yun and Zhao, Xin-Xin and Pan-Han and Li, Jun and Zhang, Ming-Wei and Zhu, Ling and Li, Qiao},
title = {Assessment of Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension},
journal = {Echocardiography},
year = {2026},
volume = {43},
number = {6},
doi = {10.1111/echo.70444}
}
EUVIMED